Trial Profile
Topology analysis of 18f-AV-1451 using PET Tau images in Alzheimer's Disease patients and healthy individuals
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Jul 2017
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- 27 Jun 2017 Results (n=82) assessing relationship between Flortaucipir uptake and changes in cognition or function over time ,presented at the 3rd Congress of the European Academy of Neurology.
- 20 Oct 2015 New trial record